A detailed history of Heathbridge Capital Management Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Heathbridge Capital Management Ltd. holds 120,200 shares of NVO stock, worth $10.5 Million. This represents 4.45% of its overall portfolio holdings.

Number of Shares
120,200
Holding current value
$10.5 Million
% of portfolio
4.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$85.0 - $120.04 $10.2 Million - $14.4 Million
120,200 New
120,200 $10.3 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Heathbridge Capital Management Ltd. Portfolio

Follow Heathbridge Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heathbridge Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Heathbridge Capital Management Ltd. with notifications on news.